DoxyPEP Is a Disaster in Waiting

Theodore Dalrymple returns to the pages of The American Conservative after a four-year hiatus to weigh in on a controversial paper published in the New England Journal of Medicine.

Our fear of appearing censorious is now so great that we remain silent in the face of any degradation and praise the grossly licentious for their altruism in seeking their own safety.


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.